The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Biodefense Market Insights and Sales Trends 2025

Biodefense Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1826917

No of Pages : 110

Ask Your Query

Synopsis
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

The global Biodefense market size is expected to reach US$ 1884.2 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Biodefense in various end use industries. The expanding demands from the US Military Market, US Civilian Market and Non - US Market,, are propelling Biodefense market. Anthrax, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Smallpox segment is estimated at % CAGR for the next seven-year period.

The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biodefense, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Biodefense market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Biodefense market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biodefense sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Biodefense covered in this report include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc.

The global Biodefense market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Emergent Biosolutions
  • Hytest
  • GSK
  • Sanofi
  • PharmAthene
  • Bavarian Nordic
  • SIGA Technologies
  • Arbutus Biopharma
  • DynPort Vaccine
  • Xoma Corporation
  • Ichor Medical Systems
  • Aeolus Pharmaceuticals
  • Achaogen
  • Elusys Therapeutics
  • Dynavax Technologies
  • Cleveland BioLabs
  • Soligenix
  • Alnylam Pharmaceuticals


Global Biodefense market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)


Global Biodefense market, Segment by Type:

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Others

Global Biodefense market, by Application

  • US Military Market
  • US Civilian Market
  • Non - US Market

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Biodefense companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Biodefense

1.1 Biodefense Market Overview

1.1.1 Biodefense Product Scope

1.1.2 Biodefense Market Status and Outlook

1.2 Global Biodefense Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Biodefense Market Size by Region (2018-2029)

1.4 Global Biodefense Historic Market Size by Region (2018-2023)

1.5 Global Biodefense Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Biodefense Market Size (2018-2029)

1.6.1 North America Biodefense Market Size (2018-2029)

1.6.2 Europe Biodefense Market Size (2018-2029)

1.6.3 Asia-Pacific Biodefense Market Size (2018-2029)

1.6.4 Latin America Biodefense Market Size (2018-2029)

1.6.5 Middle East & Africa Biodefense Market Size (2018-2029)

2 Biodefense Market by Type

2.1 Introduction

2.1.1 Anthrax

2.1.2 Smallpox

2.1.3 Botulism

2.1.4 Radiation/Nuclear

2.1.5 Others

2.2 Global Biodefense Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Biodefense Historic Market Size by Type (2018-2023)

2.2.2 Global Biodefense Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Biodefense Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Biodefense Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Biodefense Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Biodefense Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Biodefense Revenue Breakdown by Type (2018-2029)

3 Biodefense Market Overview by Application

3.1 Introduction

3.1.1 US Military Market

3.1.2 US Civilian Market

3.1.3 Non - US Market

3.2 Global Biodefense Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Biodefense Historic Market Size by Application (2018-2023)

3.2.2 Global Biodefense Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Biodefense Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Biodefense Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Biodefense Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Biodefense Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Biodefense Revenue Breakdown by Application (2018-2029)

4 Biodefense Competition Analysis by Players

4.1 Global Biodefense Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biodefense as of 2022)

4.3 Date of Key Players Enter into Biodefense Market

4.4 Global Top Players Biodefense Headquarters and Area Served

4.5 Key Players Biodefense Product Solution and Service

4.6 Competitive Status

4.6.1 Biodefense Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Emergent Biosolutions

5.1.1 Emergent Biosolutions Profile

5.1.2 Emergent Biosolutions Main Business

5.1.3 Emergent Biosolutions Biodefense Products, Services and Solutions

5.1.4 Emergent Biosolutions Biodefense Revenue (US$ Million) & (2018-2023)

5.1.5 Emergent Biosolutions Recent Developments

5.2 Hytest

5.2.1 Hytest Profile

5.2.2 Hytest Main Business

5.2.3 Hytest Biodefense Products, Services and Solutions

5.2.4 Hytest Biodefense Revenue (US$ Million) & (2018-2023)

5.2.5 Hytest Recent Developments

5.3 GSK

5.3.1 GSK Profile

5.3.2 GSK Main Business

5.3.3 GSK Biodefense Products, Services and Solutions

5.3.4 GSK Biodefense Revenue (US$ Million) & (2018-2023)

5.3.5 Sanofi Recent Developments

5.4 Sanofi

5.4.1 Sanofi Profile

5.4.2 Sanofi Main Business

5.4.3 Sanofi Biodefense Products, Services and Solutions

5.4.4 Sanofi Biodefense Revenue (US$ Million) & (2018-2023)

5.4.5 Sanofi Recent Developments

5.5 PharmAthene

5.5.1 PharmAthene Profile

5.5.2 PharmAthene Main Business

5.5.3 PharmAthene Biodefense Products, Services and Solutions

5.5.4 PharmAthene Biodefense Revenue (US$ Million) & (2018-2023)

5.5.5 PharmAthene Recent Developments

5.6 Bavarian Nordic

5.6.1 Bavarian Nordic Profile

5.6.2 Bavarian Nordic Main Business

5.6.3 Bavarian Nordic Biodefense Products, Services and Solutions

5.6.4 Bavarian Nordic Biodefense Revenue (US$ Million) & (2018-2023)

5.6.5 Bavarian Nordic Recent Developments

5.7 SIGA Technologies

5.7.1 SIGA Technologies Profile

5.7.2 SIGA Technologies Main Business

5.7.3 SIGA Technologies Biodefense Products, Services and Solutions

5.7.4 SIGA Technologies Biodefense Revenue (US$ Million) & (2018-2023)

5.7.5 SIGA Technologies Recent Developments

5.8 Arbutus Biopharma

5.8.1 Arbutus Biopharma Profile

5.8.2 Arbutus Biopharma Main Business

5.8.3 Arbutus Biopharma Biodefense Products, Services and Solutions

5.8.4 Arbutus Biopharma Biodefense Revenue (US$ Million) & (2018-2023)

5.8.5 Arbutus Biopharma Recent Developments

5.9 DynPort Vaccine

5.9.1 DynPort Vaccine Profile

5.9.2 DynPort Vaccine Main Business

5.9.3 DynPort Vaccine Biodefense Products, Services and Solutions

5.9.4 DynPort Vaccine Biodefense Revenue (US$ Million) & (2018-2023)

5.9.5 DynPort Vaccine Recent Developments

5.10 Xoma Corporation

5.10.1 Xoma Corporation Profile

5.10.2 Xoma Corporation Main Business

5.10.3 Xoma Corporation Biodefense Products, Services and Solutions

5.10.4 Xoma Corporation Biodefense Revenue (US$ Million) & (2018-2023)

5.10.5 Xoma Corporation Recent Developments

5.11 Ichor Medical Systems

5.11.1 Ichor Medical Systems Profile

5.11.2 Ichor Medical Systems Main Business

5.11.3 Ichor Medical Systems Biodefense Products, Services and Solutions

5.11.4 Ichor Medical Systems Biodefense Revenue (US$ Million) & (2018-2023)

5.11.5 Ichor Medical Systems Recent Developments

5.12 Aeolus Pharmaceuticals

5.12.1 Aeolus Pharmaceuticals Profile

5.12.2 Aeolus Pharmaceuticals Main Business

5.12.3 Aeolus Pharmaceuticals Biodefense Products, Services and Solutions

5.12.4 Aeolus Pharmaceuticals Biodefense Revenue (US$ Million) & (2018-2023)

5.12.5 Aeolus Pharmaceuticals Recent Developments

5.13 Achaogen

5.13.1 Achaogen Profile

5.13.2 Achaogen Main Business

5.13.3 Achaogen Biodefense Products, Services and Solutions

5.13.4 Achaogen Biodefense Revenue (US$ Million) & (2018-2023)

5.13.5 Achaogen Recent Developments

5.14 Elusys Therapeutics

5.14.1 Elusys Therapeutics Profile

5.14.2 Elusys Therapeutics Main Business

5.14.3 Elusys Therapeutics Biodefense Products, Services and Solutions

5.14.4 Elusys Therapeutics Biodefense Revenue (US$ Million) & (2018-2023)

5.14.5 Elusys Therapeutics Recent Developments

5.15 Dynavax Technologies

5.15.1 Dynavax Technologies Profile

5.15.2 Dynavax Technologies Main Business

5.15.3 Dynavax Technologies Biodefense Products, Services and Solutions

5.15.4 Dynavax Technologies Biodefense Revenue (US$ Million) & (2018-2023)

5.15.5 Dynavax Technologies Recent Developments

5.16 Cleveland BioLabs

5.16.1 Cleveland BioLabs Profile

5.16.2 Cleveland BioLabs Main Business

5.16.3 Cleveland BioLabs Biodefense Products, Services and Solutions

5.16.4 Cleveland BioLabs Biodefense Revenue (US$ Million) & (2018-2023)

5.16.5 Cleveland BioLabs Recent Developments

5.17 Soligenix

5.17.1 Soligenix Profile

5.17.2 Soligenix Main Business

5.17.3 Soligenix Biodefense Products, Services and Solutions

5.17.4 Soligenix Biodefense Revenue (US$ Million) & (2018-2023)

5.17.5 Soligenix Recent Developments

5.18 Alnylam Pharmaceuticals

5.18.1 Alnylam Pharmaceuticals Profile

5.18.2 Alnylam Pharmaceuticals Main Business

5.18.3 Alnylam Pharmaceuticals Biodefense Products, Services and Solutions

5.18.4 Alnylam Pharmaceuticals Biodefense Revenue (US$ Million) & (2018-2023)

5.18.5 Alnylam Pharmaceuticals Recent Developments

6 North America

6.1 North America Biodefense Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Biodefense Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Biodefense Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Biodefense Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Biodefense Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Biodefense Market Dynamics

11.1 Biodefense Industry Trends

11.2 Biodefense Market Drivers

11.3 Biodefense Market Challenges

11.4 Biodefense Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock